Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Publication Types

Journal Article

Clinical Trial

Comparative Study

Research Support, Non-U.S. Gov't

Randomized Controlled Trial

Review

Case Reports

Research Support, U.S. Gov't, P.H.S.

Evaluation Study

Multicenter Study

Publication Year

From

Quick links

Individual year

2021

2013

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Pirenzepine""[mesh_terms]

18 Results

Searching titles within these results

Olanzapine-associated severe hyperglycemia, ketonuria, and acidosis: case report and review of literature.

H L Seaburg, B M McLendon, P M Doraiswamy

Pharmacotherapy 2002;21(11):1448-54

Full Text

Abstract

Olanzapine-associated diabetes mellitus.

Elizabeth A Koller, P Murali Doraiswamy

Pharmacotherapy 2003;22(7):841-52

Full Text

Abstract

Effects of pirenzepine on vonoprazan-induced gastric acid inhibition and hypergastrinemia.

Takahiro Suzuki, Tomohiro Higuchi, Takuma Kagami, Takahiro Uotani, Mihoko Yamade, Shinya Tani, Yasushi Hamaya, Moriya Iwaizumi, Satoshi Osawa, Ken Sugimoto, Hiroaki Miyajima, Takahisa Furuta

European journal of clinical pharmacology 2021;77(7):971-978

Full Text

Abstract

Atypical antipsychotics and hyperglycaemia.

S Mir, D Taylor

International clinical psychopharmacology 2001;16(2):63-73

Full Text

Abstract

A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder.

Alan C Swann, Patricia Wozniak, John M Zajecka, Richard Weisler, Gary Sachs, Kenneth W Sommerville

The Journal of clinical psychiatry 2003;63(12):1148-55

Full Text

Abstract

Muscarinic cholinergic mediation of the GH response to gamma-hydroxybutyric acid: neuroendocrine evidence in normal and parkinsonian subjects.

R Volpi, P Chiodera, P Caffarra, A Scaglioni, L Malvezzi, A Saginario, V Coiro

Psychoneuroendocrinology 2000;25(2):179-85

Full Text

Abstract

Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine.

Doron Gothelf, Bareket Falk, Pierre Singer, Michal Kairi, Moshe Phillip, Levana Zigel, Irit Poraz, Siegal Frishman, Naama Constantini, Gil Zalsman, Abraham Weizman, Alan Apter

The American journal of psychiatry 2002;159(6):1055-7

Full Text

Abstract

Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes.

S Hägg, O Spigset, H A Lakso, R Dahlqvist

European journal of clinical pharmacology 2002;57(6-7):493-7

Full Text

Abstract

Antipsychotic drugs and QT interval prolongation.

Wojciech Zareba, David A Lin

The Psychiatric quarterly 2003;74(3):291-306

Full Text

Abstract

Exploration of the orthosteric/allosteric interface in human M1 muscarinic receptors by bitopic fluorescent ligands.

Brigitte Ilien, Jean-Luc Galzi, Valérie Utard, Dominique Bonnet, Esther Kellenberger, Sandrine B Daval

Molecular pharmacology 2013;84(1):71-85

Full Text

Abstract

D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study.

E M Meisenzahl, S Dresel, T Frodl, G J Schmitt, U W Preuss, B Rossmüller, K Tatsch, T Mager, K Hahn, H J Möller

Journal of psychopharmacology (Oxford, England) 2001;14(4):364-70

Full Text

Abstract

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.

Jean-Pierre Lindenmayer, Pal Czobor, Jan Volavka, Leslie Citrome, Brian Sheitman, Joseph P McEvoy, Thomas B Cooper, Miranda Chakos, Jeffrey A Lieberman

The American journal of psychiatry 2003;160(2):290-6

Full Text

Abstract

Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine.

Julio Benítez, Sonia Vizcaíno, Guillermo Gervasini, Sara Isabel Ramos, Juan Antonio Carrillo, Angustias G Herráiz

Journal of clinical psychopharmacology 2003;23(2):119-27

Full Text

Abstract

High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia.

Daniel C Javitt, Gali Bar, Pesah Lichtenberg, Marina Ermilov, Uriel Heresco-Levy

Biological psychiatry 2004;55(2):165-71

Full Text

Abstract

A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.

G S Sachs, S N Ghaemi, C Guille

The Journal of clinical psychiatry 2000;61(9):638-42

Full Text

Abstract

Results: 1 – 15 / 18

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Pirenzepine""[mesh_terms]

Olanzapine-associated severe hyperglycemia, ketonuria, and acidosis: case report and review of literature.

Olanzapine-associated diabetes mellitus.

Effects of pirenzepine on vonoprazan-induced gastric acid inhibition and hypergastrinemia.

Atypical antipsychotics and hyperglycaemia.

A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder.

Muscarinic cholinergic mediation of the GH response to gamma-hydroxybutyric acid: neuroendocrine evidence in normal and parkinsonian subjects.

Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine.

Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes.

Antipsychotic drugs and QT interval prolongation.

Exploration of the orthosteric/allosteric interface in human M1 muscarinic receptors by bitopic fluorescent ligands.

D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study.

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.

Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine.

High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia.

A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.

Results for
""Pirenzepine""[mesh_terms]